lobbying_activities: 843661

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
843661	e86c173c-11c0-4890-bfb1-0c0ac33ac481	Q3	APOTEX CORP.	310973	APOTEX CORP.	2009	third_quarter	PHA	S. 369, the Preserve Access to Affordable Pharmaceuticals Act HR 1706, the Protecting Consumer Access to Generic Drugs Act S. 1315, the Drug Price Competition Act of 2009 HR 3200, Subtitle C - Food & Drug Administration, Section 2563, Protecting Consumer Access to Generic Drugs HR 3200, Subtitle C, Food & Drug Administration, Part 2, Biosimilars Section 2565, Licensure Pathway for Biosimilar Biological Products HR 1427, the Promoting Innovation and Access to Life Savings Medicine Act HR 1548, Pathway for Biosimilars Act	Congressional Budget Office (CBO),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE		150000	0	0	2009-10-20T09:59:27-04:00